OWIM
MDGL icon

Old West Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Old West Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,000
Closed -$301K – 84
2014
Q1 		$301K Sell
2,000
-26
-1% -$5.12K 0.19% 80
2013
Q4 		$371K Buy
2,026
+622
+44% +$114K 0.22% 80
2013
Q3 		$310K Buy
1,404
+554
+65% +$118K 0.15% 77
2013
Q2 		$148K Buy
+850
New +$222K 0.07% 77

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Old West Investment Management's MDGL Position: Q2 2014 in Review

Old West Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2014, closing a stake of 2,000 shares — an estimated $301K sold.

Old West Investment Management first reported a position in MDGL in Q2 2013 and held it in 4 quarters. The position peaked at $371K in Q4 2013. 82 funds tracked by Wall St. Rank hold MDGL as of Q2 2014.

  • Old West Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Old West Investment Management sold 2,000 Madrigal Pharmaceuticals shares in Q2 2014, an estimated $301K.
  • Old West Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Old West Investment Management's Madrigal Pharmaceuticals position peaked at $371K in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2014.

Based on Old West Investment Management's 13F filing for Q2 2014, filed 11 Aug 2014.